Michael A. Caligiuri
Impact in
- Immunology top 0.01%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- IL-33, ST2, and ILC Pathways
- Reproductive System and Pregnancy
- Hematology top 0.02%
- Acute Myeloid Leukemia Research
Papers in
- Immunology 249
- Immune Cell Function and Interaction 217
- T-cell and B-cell Immunology 88
- IL-33, ST2, and ILC Pathways 36
- Oncology 125
- CAR-T cell therapy research 68
- Co-authors
- Todd A. Fehniger (27 shared papers)Megan A. Cooper (11 shared papers)Jianhua Yu (120 shared papers)Aharon G. Freud (40 shared papers)Guido Marcucci (87 shared papers)Clara D. Bloomfield (60 shared papers)William E. Carson (29 shared papers)Brian Becknell (33 shared papers)
- Journals
- Blood (133 papers)The Journal of Immunology (27 papers)Clinical Cancer Research (17 papers)Journal of Clinical Oncology (16 papers)Journal of Clinical Investigation (15 papers)
- Partner nations
- United StatesChinaItaly
In The Last Decade
Michael A. Caligiuri
441 papers receiving 48.1k citations
Michael A. Caligiuri's Hit Papers
Peers
Comparison fields: 5 of 164
- Immunology 25.6k
- Hematology 9.4k
- Oncology 13.5k
- Cancer Research 4.9k
- Genetics 3.4k
Countries citing papers authored by Michael A. Caligiuri
This map shows the geographic impact of Michael A. Caligiuri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Caligiuri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Caligiuri more than expected).
Fields of papers citing papers by Michael A. Caligiuri
This network shows the impact of papers produced by Michael A. Caligiuri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Caligiuri. The network helps show where Michael A. Caligiuri may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael A. Caligiuri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 448 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A cell initiating human acute myeloid leukaemia after transplantation into SCID mice Hit paper breakdown → | 1994 | 3779 |
| 2 | The biology of human natural killer-cell subsets Hit paper breakdown → | 2001 | 2432 |
| 3 | Innate or Adaptive Immunity? The Example of Natural Killer Cells Hit paper breakdown → | 2011 | 2153 |
| 4 | Human natural killer cells Hit paper breakdown → | 2008 | 1525 |
| 5 | MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response Hit paper breakdown → | 2012 | 1346 |
| 6 | Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset Hit paper breakdown → | 2001 | 1179 |
| 7 | Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. Hit paper breakdown → | 1994 | 973 |
| 8 | Interleukin 15: biology and relevance to human disease Hit paper breakdown → | 2001 | 827 |
| 9 | CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity Hit paper breakdown → | 2003 | 700 |
| 10 | The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibody Hit paper breakdown → | 2010 | 682 |
| 11 | Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver Hit paper breakdown → | 2012 | 649 |
| 12 | Obesity, Inflammation, and Cancer Hit paper breakdown → | 2016 | 646 |
| 13 | IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study Hit paper breakdown → | 2010 | 584 |
| 14 | Differential Cytokine and Chemokine Gene Expression by Human NK Cells Following Activation with IL-18 or IL-15 in Combination with IL-12: Implications for the Innate Immune Response Hit paper breakdown → | 1999 | 565 |
| 15 | The Broad Spectrum of Human Natural Killer Cell Diversity Hit paper breakdown → | 2017 | 507 |
| 16 | Coordinated and Distinct Roles for IFN-αβ, IL-12, and IL-15 Regulation of NK Cell Responses to Viral Infection Hit paper breakdown → | 2002 | 504 |
| 17 | 2002 | 403 | |
| 18 | 2003 | 399 | |
| 19 | 2005 | 397 | |
| 20 | 2013 | 393 |
About Michael A. Caligiuri
Michael A. Caligiuri is a scholar working on Immunology, Oncology, Hematology, Molecular Biology and Genetics, having authored 448 papers that have together received 49.2k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (217 papers), T-cell and B-cell Immunology (88 papers), Acute Myeloid Leukemia Research (72 papers), CAR-T cell therapy research (68 papers), IL-33, ST2, and ILC Pathways (36 papers), Chronic Myeloid Leukemia Treatments (32 papers), Lymphoma Diagnosis and Treatment (31 papers) and Chronic Lymphocytic Leukemia Research (31 papers). The work is most often cited by research in Immunology (25.6k citations), Hematology (9.4k citations), Oncology (13.5k citations), Cancer Research (4.9k citations) and Genetics (3.4k citations). Michael A. Caligiuri has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Todd A. Fehniger, Megan A. Cooper, Jianhua Yu, Aharon G. Freud, Guido Marcucci, Clara D. Bloomfield, William E. Carson, Brian Becknell, Mark D. Minden and Barbara Murdoch. Their work appears in journals such as Blood, The Journal of Immunology, Clinical Cancer Research, Journal of Clinical Oncology and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.